Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06522685 · ClinicalTrials.gov registry record · NA
Neural and Immune Correlates of CIPN and Possible Analgesic Effect of Non-invasive Motor Cortex Stimulation
A NA study, sponsored by Morgan State University.
- Not yet
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT06522685 is a NA study that has not yet begun recruiting, run by Morgan State University. The registered enrollment target is 80 participants.
The verdict
NCT06522685, a NA study, has not yet begun recruiting, sponsored by Morgan State University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
Over half of cancer patients receiving common chemotherapy treatments experience painful nerve damage called chemotherapy-induced peripheral neuropathy (CIPN). Non-Hispanic Black (NHB) patients are more likely to suffer from this condition and more often need to reduce their chemotherapy doses compared to Non-Hispanic White (NHW) patients. Currently, only one medication, duloxetine, is approved for treating CIPN, but it doesn't work for everyone. A new approach, transcranial direct current stimulation (tDCS), shows promise as a safe and effective treatment. tDCS can be done at home and reduces the need for hospital visits. Research indicates that tDCS can improve pain responses in the brain's pain control network. There are differences in pain sensitivity and brain activity related to pain between NHB and NHW individuals, which may influence the effectiveness of treatments. This research aims to conduct a study to: 1. Test if tDCS is a helpful treatment for painful CIPN. 2. Investigate how CIPN affects brain function in NHB and NHW patients. 3. Examine the role of inflammation in CIPN and its connection to pain severity and brain function. The investigators expect that NHB patients will benefit more from tDCS due to differences in their brain's pain response system. This project aims to address health disparities and improve outcomes for urban communities, particularly in Baltimore.
Interventions
- DEVICE transcranial direct current stimulation Soterix REMOTE 1x1 miniCT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06522685
The ClinicalTrials.gov registry entry for NCT06522685 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Morgan State University, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which transcranial direct current stimulation Soterix REMOTE 1x1 miniCT is the first listed.
NCT06522685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06522685 about?
NCT06522685 is a clinical study titled "Neural and Immune Correlates of CIPN and Possible Analgesic Effect of Non-invasive Motor Cortex Stimulation". Over half of cancer patients receiving common chemotherapy treatments experience painful nerve damage called chemotherapy-induced peripheral neuropathy (CIPN). Non-Hispanic Black (NHB) patients are more likely to suffer from this condition and more often need to reduce their chemotherapy doses compa...
What is the current status of trial NCT06522685?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2025-03-01. Estimated completion is 2029-06-30.
What interventions are being tested in trial NCT06522685?
The interventions under investigation include: transcranial direct current stimulation Soterix REMOTE 1x1 miniCT (DEVICE).
Who is sponsoring clinical trial NCT06522685?
This trial is sponsored by Morgan State University, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.